Transdermal HRT Not Linked to Increased Risk for VTE

Share this content:
Transdermal HRT Not Linked to Increased Risk for VTE
Transdermal HRT Not Linked to Increased Risk for VTE

THURSDAY, Jan. 10, 2019 (HealthDay News) -- Oral hormone replacement therapy (HRT) is associated with an increased risk for venous thromboembolism (VTE), while transdermal preparations are not linked to increased risk, according to a study published online Jan. 9 in the BMJ.

Yana Vinogradova, Ph.D., from the University of Nottingham in the United Kingdom, and colleagues conducted two nested case-control studies involving 80,396 women aged 40 to 79 years with a primary diagnosis of VTE and 391,494 matched female controls.

The researchers found that 7.2 and 5.5 percent of women who had VTE and controls, respectively, had been exposed to HRT within 90 days before the index date. Of these two groups, 85 and 78 percent, respectively, used oral therapy, correlating with a significantly increased risk for VTE versus no exposure (adjusted odds ratio, 1.58). The risk was increased for estrogen-only preparations and for combined preparations (adjusted odds ratios, 1.4 and 1.73, respectively). For estrogen-only preparations and combined preparations, estradiol was associated with a lower risk than conjugated equine estrogen (odds ratios, 0.85 and 0.83, respectively). The highest and lowest risks were seen for equine estrogen with medroxyprogesterone acetate and estradiol with dydrogesterone (2.1 and 1.18, respectively) compared with no exposure. There was no correlation between transdermal preparations and risk for VTE.

"Transdermal HRT or tibolone, used much less frequently, are not associated with any increased VTE risk," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »